Not finding it? Sign in to also search OpenAlex live.
-
Weight loss and blood pressure lowering with GLP-1 receptor agonists and multi-hormone receptor modulators in overweight and obesity: a systematic review and meta-regression of phase 3 clinical trials
Massimo Nardone, Luxcia Kugathasan, Lauren Daunt, Ethan J. Parikh, Hao-Yuan River Zhang, Sachin Vidur Pasricha, +4 more
0citations -
Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials2026 SKIN The Journal of Cutaneous Medicine article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access
Joseph Frank Merola, April Armstrong, Deepak Balak, Jason Ezra Hawkes, Leon Kircik, Fiona E. Lovegrove, +4 more
0citations -
Phase-adaptive automated whole-liver quantification of signal intensity-derived liver indices from gadoxetic acid-enhanced MRI2026 European Radiology Experimental article Computer Science Medical Image Segmentation Techniques Open access
Felix Barajas Ordonez, Simon Westfechtel, Fadi Matar, Christian Schmidt, J Lemessa, Patrick Wienholt, +4 more
0citations -
Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.2024 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management Open access
Christian U. Blank, Minke W. Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander Maxwell Menzies, Marta López‐Yurda, +14 more
27citations -
STAR-TREC phase II: Can we save the rectum by watchful waiting or transanal surgery following (chemo)radiotherapy versus total mesorectal excision for early rectal cancer?2022 Journal of Clinical Oncology conference-abstract Medicine Colorectal Cancer Surgical Treatments
Simon Parkinson Bach, Johannes H.W. de Wilt, Femke P. Peters, Karen‐Lise Garm Spindler, Ane Lindegaard Appelt, Mark T.W. Teo, +14 more
19citations -
Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial2020 The Lancet Infectious Diseases article Medicine Viral Infections and Outbreaks Research Open access cited by 7 patents
Andrew John Pollard, Odile Launay, Jean‐Daniel Lelièvre, Christine Lacabaratz, Sophie Grande, Neil H. Goldstein, +84 more
173citations -
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous KIT/PDGFRA Mutations in the Phase III INVICTUS Study2021 Clinical Cancer Research article Medicine Gastrointestinal Tumor Research and Treatment Open access
Sebastian Bauer, Michael Charles Heinrich, Suzanne George, John Raymond Zalcberg, César Serrano, Hans A. J. Gelderblom, +11 more
46citations -
Consensus‐Based Technical Recommendations for Clinical Translation of Renal Phase Contrast MRI2020 Journal of Magnetic Resonance Imaging article Medicine Advanced MRI Techniques and Applications Open access
A de Boer, Giulia Villa, Octavia Bane, Michael Bock, Eleanor F. Cox, Ilona A. Dekkers, +22 more
39citations -
Sialic Acid Derivatization of Fluorescently Labeled N-Glycans Allows Linkage Differentiation by Reversed-Phase Liquid Chromatography–Fluorescence Detection–Mass Spectrometry2022 Analytical Chemistry article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access cited by 1 patent
Alan B. Moran, Richard A. Gardner, Manfred Wuhrer, Guinevere S. M. Lageveen‐Kammeijer, Daniel I. R. Spencer
26citations -
Deep learning for 3D vascular segmentation in hierarchical phase contrast tomography: a case study on kidney2024 Scientific Reports article Computer Science Medical Image Segmentation Techniques Open access cited by 1 patent
Ekin Yağış, Shahab Aslani, Yashvardhan Jain, Yang Zhou, Shahrokh Rahmani, Joseph Brunet, +7 more
25citations -
Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)
Jaap C. Reijneveld, Abigirl Machingura, Corneel Coens, MARTIN J.B. TAPHOORN, Walter Taal, Paul M. Clément, +10 more
13citations -
Temporal patterns of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC).2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
George K.K. Lau, Bruno Sangro, Oxana Crysler, Wattana Sukeepaisarnjaroen, Oleg Nikolaevich Lipatov, Manabu Morimoto, +12 more
8citations